Mohamed Khairie Issa
At a glance: Mohamed Khairie Issa is Evp, Head Of U.S. Commercial at Incyte (INCY). Their latest SEC Form 4, filed Jul 20, 2026, reported a sale of $126K. On file: 0 purchase lines ($0) and 2 sale lines ($1.3M).
Disclosed holdings: about $7.4M of INCY stock: 63,940 shares reported on their latest Form 4 (filed Jul 20, 2026), valued at the Nov 19, 2026 close of $115.96. This counts only INCY shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp, Head Of U.S. Commercial at Incyte Corp (INCY); Evp, Head Of Us Oncology at Incyte Corp (INCY)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Mohamed Khairie Issa's InsiderPrint
2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 20SEC | INCYIncyte Corp | Sell Plan | 1,09363,940 held (−2%) | $115.01 | $126K | +0.8% |
| Jan 8SEC | INCYIncyte Corp | Sell Plan | 10,85666,132 held (−14%) | $109.07 | $1.2M | +6.3% |
- Sell
Evp, Head Of U.S. Commercial Mohamed Khairie Issa sold $126K of INCY at $115.01 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of Us Oncology Mohamed Khairie Issa sold $1.2M of INCY at $109.07 — pre-scheduled 10b5-1 plan sale.
Follow Mohamed Khairie Issa
Get one email when Mohamed Khairie Issa files a new purchase or sale. Free.
At most one email a day about Mohamed Khairie Issa, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.